124 related articles for article (PubMed ID: 7524525)
1. Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects.
Grevengood C; Shulman LP; Dungan JS; Martens P; Phillips OP; Emerson DS; Felker RE; Simpson JL; Elias S
Fetal Diagn Ther; 1994; 9(4):273-7. PubMed ID: 7524525
[TBL] [Abstract][Full Text] [Related]
2. Family planning decisions after prenatal detection of fetal abnormalities.
Shulman LP; Grevengood C; Phillips OP; Gross SJ; Mace PC; Elias S
Am J Obstet Gynecol; 1994 Nov; 171(5):1373-6. PubMed ID: 7977549
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
[TBL] [Abstract][Full Text] [Related]
4. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
[TBL] [Abstract][Full Text] [Related]
5. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
[TBL] [Abstract][Full Text] [Related]
7. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
[TBL] [Abstract][Full Text] [Related]
8. Results and benefits of a maternal serum alpha-fetoprotein screening program.
Milunsky A; Alpert E
JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
[TBL] [Abstract][Full Text] [Related]
9. Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
Kooper AJ; de Bruijn D; van Ravenwaaij-Arts CM; Faas BH; Creemers JW; Thomas CM; Smits AP
Prenat Diagn; 2007 Jan; 27(1):29-33. PubMed ID: 17154227
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic ultrasound: early detection of fetal neural tube defects.
Robinson HP; Hood VD; Adam AH; Gibson AA; Ferguson-Smith MA
Obstet Gynecol; 1980 Dec; 56(6):705-10. PubMed ID: 6160439
[TBL] [Abstract][Full Text] [Related]
11. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
12. [The alpha-fetoprotein level analysis in open neural tube defects and chromosomal aberrations in the fetus].
Ilnicka A; Pawłowska B; Czyzewska J; Głogowska I; Korlak J; Rodo M; Bieganowska K; Szirkowiec W; Zdzienicka E; Zaremba J
Neurol Neurochir Pol; 1996; 30(1):65-75. PubMed ID: 8657351
[TBL] [Abstract][Full Text] [Related]
13. The detection of neural tube closure defects by exfoliative cytology of amniotic fluid.
Chapman PA; Blenkinsopp WK; Lewis BV
Acta Cytol; 1981; 25(4):367-72. PubMed ID: 6169246
[TBL] [Abstract][Full Text] [Related]
14. Screening for neural tube defects.
Cuckle HS
Ciba Found Symp; 1994; 181():253-66; discussion 266-9. PubMed ID: 7516277
[TBL] [Abstract][Full Text] [Related]
15. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R
Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis and elective termination of neural tube defects in Hawaii, 1986-1997.
Forrester MB; Merz RD
Fetal Diagn Ther; 2000; 15(3):146-51. PubMed ID: 10781998
[TBL] [Abstract][Full Text] [Related]
17. Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
Lopez J; Mikaelian I; Gonzalo P
Prenat Diagn; 2013 Oct; 33(10):990-5. PubMed ID: 23784867
[TBL] [Abstract][Full Text] [Related]
18. Amniotic fluid test for the diagnosis of neural tube defects.
Lituania M; Canini S; Cordone M; Lenzi A
J Nucl Med Allied Sci; 1989; 33(3 Suppl):63-6. PubMed ID: 2480426
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
[TBL] [Abstract][Full Text] [Related]
20. Cut-off levels for maternal plasma alpha-fetoprotein in the diagnosis of neural tube defects: validation of the use of multiples of the normal median.
Tovey KC; Gerson M
Br J Obstet Gynaecol; 1979 Jul; 86(7):507-15. PubMed ID: 89862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
